Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.
Bloomberg Businessweek
4,384 clip(s)
Morgan Stanley Shift Bears Fruit, Momentum Slows
Elevating Free Speech to Advance Equality and Democracy
BofA Shares Rise After Beat on Net Interest Income